CRP and metabolic syndrome: Moreover, the observed associations between elevated TG (OR = 1.61, 95% CI: 1.18–2.20) and CRP levels (OR = 1.85, 95% CI: 1.24–2.77) in patients at high risk of cholestatic DILI indicate concurrent dyslipidemia and systemic inflammation may potentiate hepatic lipotoxicity through enhanced lipid synthesis (27).